Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era. Read more about Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era.
Reducing Opioid Use in Endocrine Surgery Through Patient Education and Provider Prescribing Patterns. Read more about Reducing Opioid Use in Endocrine Surgery Through Patient Education and Provider Prescribing Patterns.
Postoperative Hypoparathyroidism After Total Thyroidectomy in Children. Read more about Postoperative Hypoparathyroidism After Total Thyroidectomy in Children.
Low-Risk Thyroid Cancer in Elderly: Total Thyroidectomy/RAI Predominates but Lacks Survival Advantage. Read more about Low-Risk Thyroid Cancer in Elderly: Total Thyroidectomy/RAI Predominates but Lacks Survival Advantage.
Technical Innovation in Transoral Endoscopic Endocrine Surgery: A Modified "Scarless" Technique. Read more about Technical Innovation in Transoral Endoscopic Endocrine Surgery: A Modified "Scarless" Technique.
Postoperative Pain and Opioid Use After Thyroid and Parathyroid Surgery-A Pilot, Prospective SMS-Based Survey. Read more about Postoperative Pain and Opioid Use After Thyroid and Parathyroid Surgery-A Pilot, Prospective SMS-Based Survey.
Trends in Adrenal Surgery-The Changing Nature of Tumors and Patients. Read more about Trends in Adrenal Surgery-The Changing Nature of Tumors and Patients.
Treatment of Primary Aldosteronism Reduces the Probability of Obstructive Sleep Apnea. Read more about Treatment of Primary Aldosteronism Reduces the Probability of Obstructive Sleep Apnea.
Interventions and Innovation to Prevent Surgical Site Infection in Colorectal Surgery: A Cost-Effectiveness Analysis. Read more about Interventions and Innovation to Prevent Surgical Site Infection in Colorectal Surgery: A Cost-Effectiveness Analysis.
Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases. Read more about Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases.